Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer.

Targeting chromosomal instability and tumour heterogeneity in HER2-positive breast cancer. J Cell Biochem. 2010 Nov 01; 111(4):782-90.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.